# A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients

> **NCT06771063** · PHASE2 · RECRUITING · sponsor: **Cisen Pharmaceutical CO., LTD.** · enrollment: 108 (estimated)

## Conditions studied

- Vaginitis

## Interventions

- **DRUG:** WXSH0102/placebo
- **DRUG:** fluconazole capsules/placebo

## Key facts

- **NCT ID:** NCT06771063
- **Lead sponsor:** Cisen Pharmaceutical CO., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2025-07-10
- **Final completion:** 2025-07-31
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06771063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06771063, "A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06771063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*